Lexington, Massachusetts Clinical Trials

A listing of Lexington, Massachusetts clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 82 clinical trials
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

dementia
pick's disease
aphasia
progranulin
Massachusetts General Hospital
 (9.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +46 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

lasmiditan
treatment regimen
headache
migraine
ly573144
MedVadis Research Corp
 (4.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +162 other locations
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

This trial studies how well atezolizumab added to the usual radiation therapy works in treating patients with stage I-IIA non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow …

stage ia2 lung cancer ajcc v8
neutrophil count
stage ib lung cancer ajcc v8
stereotactic body radiation therapy
stage ia1 lung cancer ajcc v8
Lahey Hospital and Medical Center
 (2.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +21 other locations
Pilot Study of the Haymakers for Hope Fitness Program

This research study is assessing the effect of an exercise program on cancer survivors. The exercise program is Haymakers for Hope 16-week exercise program

melanoma
myocardial infarction
neuropathy
cancer diagnosis
peripheral neuropathy
Massachusetts General Hospital Cancer Center
 (9.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
An Efficacy and Safety Study of Ravulizumab in ALS Participants

The purpose of the study is to assess the efficacy and safety of ravulizumab for the treatment of adult participants with ALS.

riluzole
edaravone
ravulizumab
vaccination
Massachusetts General Hospital
 (9.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
ELUCIDATE: Enabling LUng Cancer IDentification Using folATE Receptor Targeting

This is a phase 3, multi-center, single dose, open-label, exploratory study in suspected lung cancer patients scheduled to undergo endoscopic or thoracic surgery per CT/PET/MRI or other imaging based on standard of care. This study aims to assess the efficacy of OTL38 and Near Infrared Imaging (NIR) at identifying pulmonary …

wedge resection
thoracoscopy
wedge excision
lung cancer
thoracic surgery
Beth Israel Deaconess Medical Center
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +4 other locations
Mechanism of Action of Transcranial Magnetic Stimulation

This is an observational neuroimaging study assessing the effects of TMS on the brains of patients with unipolar depression.

psychiatric therapy
depressive disorder
major depressive disorder
psychiatric treatment
depression
Massachusetts General Hospital
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
ATR Inhibitor BAY 1895344 Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

The purpose of the study is to test how well patients with advanced solid tumors and ovarian cancer respond to treatment with BAY1895344 in combination with niraparib. In addition researchers want to find for patients the optimal dose of BAY1895344 in combination with niraparib, how the drug is tolerated and …

neutrophil count
prostate cancer
ovarian cancer
platelet count
muga scan
Dana-Farber Cancer Institute
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
Ibrutinib + Venetoclax in Untreated WM

This study evaluates the safety and efficacy of Ibrutinib combined with Venetoclax (IVEN) in the treatment of adults diagnosed with Waldenstrom's macroglobulinemia (WM) cancer with a specific MYD88 gene mutation. This research study involves an experimental drug combination of targeted therapies. The names of the study drugs involved in this …

neutrophil count
absolute neutrophil count
plasmapheresis
myd88 gene mutation
venetoclax
Dana Farber Cancer Institute
 (9.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer

The primary objective of this study is to evaluate the safety and tolerability of H3B-6545 and palbociclib when administered in combination in order to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of this combination in women with advanced or metastatic estrogen receptor-positive (ER+) HER2- …

epidermal growth factor
estrogen receptor
her2/neu-negative breast cancer
her2- breast cancer
estrogen
Massachusetts General Hospital
 (9.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations